DalsnaFinance

AGP & DTx Summit: Digital therapeutics show 0.54% HbA1c reduction as diabetes care moves from monitoring to change

Markets PR Newswire By PR Newswire 04 Jun 2026 10:52 1 min read
AGP & DTx Summit: Digital therapeutics show 0.54% HbA1c reduction as diabetes care moves from monitoring to change

SHENZHEN, China, June 4, 2026 /PRNewswire/ -- In May 2026, the 4th AGP & DTx Summit concluded successfully in Shenzhen under the theme "Beyond Glucose." With SIBIONICS serving as a co-organizer, the summit brought together international experts, healthcare professionals, researchers,...

SHENZHEN, China, June 4, 2026 /PRNewswire/ -- In May 2026, the 4th AGP & DTx Summit concluded successfully in Shenzhen under the theme "Beyond Glucose." With SIBIONICS serving as a co-organizer, the summit brought together international experts, healthcare professionals, researchers,...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.